InvestSMART

Invion Limited (ASX: IVX) - Announcements

Current share price for IVX : $0.040 0.004 (11.11%)+

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Demerger - clarification on eligible shareholders 7 Sep 2018 8:29AM $0.036 $0.040 risen by 11.11%
$4 Spin out of respiratory assets for development in China 5 Sep 2018 8:26AM $0.037 $0.040 risen by 8.11%
$4 Highlights of financial and operating results for FY2018 28 Aug 2018 2:59PM $0.036 $0.040 risen by 11.11%
$4 Corporate Governance Statement 28 Aug 2018 11:59AM $0.037 $0.040 risen by 8.11%
$4 Appendix 4G - Key to Governance Disclosures 28 Aug 2018 11:57AM $0.037 $0.040 risen by 8.11%
$4 Appendix 4E Annual Report and Full Year Statutory Accounts 28 Aug 2018 11:51AM $0.037 $0.040 risen by 8.11%
$4 Appendix 4C - June 2018 quarter 27 Jul 2018 3:45PM $0.040 $0.040 fallen by 0%
$4 Photosoft efficiently destroys ovarian cancer cells in vitro 5 Jul 2018 8:28AM $0.033 $0.040 risen by 21.21%
$4 Appendix 3B - shares issued upon exercise of options 29 May 2018 10:53AM $0.028 $0.040 risen by 42.86%
$4 Appendix 3B - shares issued on exercise of options 22 May 2018 11:51AM $0.033 $0.040 risen by 21.21%
$4 Appendix 3B - issue of shares following options exercise 14 May 2018 5:37PM $0.036 $0.040 risen by 11.11%
$4 Appendix 3B - issue of shares following options exercise 10 May 2018 7:30PM $0.037 $0.040 risen by 8.11%
$4 Shareholder Newsletter 30 Apr 2018 8:19AM $0.035 $0.040 risen by 14.29%
$4 Appendix 3B - issue of shares following options exercise 30 Apr 2018 8:19AM $0.035 $0.040 risen by 14.29%
$4 App 3B - issue of 10M shares following option exercise 26 Apr 2018 6:18PM $0.038 $0.040 risen by 5.26%
$4 Appendix 4C - March 2018 quarter 26 Apr 2018 8:31AM $0.035 $0.040 risen by 14.29%
$4 App 3B - issue of 2M shares following option exercise 19 Apr 2018 8:29AM $0.026 $0.040 risen by 53.85%
$4 Appendix 3Y - change to director interests Mitchell Glass 18 Apr 2018 9:24AM $0.033 $0.040 risen by 21.21%
$4 Appendix 3B - unlisted share options 17 Apr 2018 3:57PM $0.034 $0.040 risen by 17.65%
$4 Response to ASX Price Query 29 Mar 2018 2:07PM $0.037 $0.040 risen by 8.11%
$4 Final Director's Interest Notice 22 Mar 2018 4:00PM $0.028 $0.040 risen by 42.86%
$4 Change to Board of Invion - retirement of Mr Warren Brown 22 Mar 2018 3:56PM $0.028 $0.040 risen by 42.86%
$4 Appointment of Dr Andrew Stephens to Advisory Board 21 Mar 2018 8:27AM $0.027 $0.040 risen by 48.15%
$4 Invion alliance with Hudson Institute of Medical Research 20 Mar 2018 9:45AM $0.019 $0.040 risen by 110.53%
$4 Appendix 3Y - Chew 19 Mar 2018 8:22AM $0.019 $0.040 risen by 110.53%

476 - 500 of 717 results

Page 20 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.